Kenneth Cunningham

Kenneth Cunningham, listed as senior executive, appears in our data through filings on Verona Pharma plc shares, published by SEC (Form 4). The record holds 3 filings, for trades running from 4 May 2021 to 7 October 2025.

Every open-market trade on record is a sale: 1 sale worth €9,164. Besides market trades, the filings include 1 option exercise.

The newest entry dates from 8 October 2025: a transaction, in Verona Pharma plc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.